Landscapes / Companies
Hope Biosciences Research Foundation not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 5 in all
Trials
2 active
10 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Hope Biosciences |
Phase 2 | Jan 2027Phase 2 trial completes | ||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2027Phase 2 trial completes | |||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Crohn Disease (CD) | ||||
| Open drug page | |||||
About
- No active trial
- Allogeneic HB-adMSCs, allogeneic Hope Biosciences adipose-derived mesenchymal stem cells, HB-adMSC
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021